Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

Advances in electrosurgical techniques have helped thousands of transcatheter valve patients
Toby Rogers, MD, associate professor of medicine at Georgetown University and an interventional cardiologist at MedStar, explains how electrosurgical procedures for transcaval access have helped large numbers of patients receive transcatheter heart valves who otherwise would have been disqualified due to anatomical issues.
3D echo guidance seeing increasing use in congenital heart surgery
Pei-Ni Jone, MD, FASE, director, echocardiography laboratory, Lurie Children’s Hospital Heart Center, member of the American Society of Echocardiography (ASE) Board, explains how 3D echo is being used to better plan, guide and follow up in congenital cardiac surgery.
ESC Congress broke new record with over 33,000 attendees
The European Society of Cardiology had nearly twice as many attendees as ACC this year, as the European meeting secures its place as the largest cardiology meeting in the world.
Johnson & Johnson’s PFA platform is both safe and effective, real-world data confirm
The Varipulse PFA platform, which has already received FDA and CE mark approval, was linked to an adverse event rate of just 0.6%.
Real-world data link semaglutide, tirzepatide to improved heart failure outcomes
GLP-1 drugs have been taking the United States by storm in recent years. According to a new study of more than 90,000 patients, some of these medications can also make a big impact on reducing adverse heart failure outcomes.

Examples of new cardiac CT technologies at the 2022 SCCT meeting. Top left clockwise, realistic 3D rendering inside the heart, the GE Revolution Apex scanner, Cleerly's AI automated soft plaque assessment, and CT strain imaging from Medis. #SCCT #SCCT2022 #YesCCT #CTA #CCTA, new computed tomography technology

PHOTO GALLERY: Cardiac CT advances at SCCT 2022

View a variety of images from the 2022 Society of Cardiovascular Computed Tomography (SCCT) meeting in Las Vegas.

What new research tells us about the significant heart damage associated with COVID-19

“We found direct evidence that the SARS-CoV-2 spike protein is toxic to heart muscle cells," one researcher said.

Example of a patient's coronary tree extracted from a cardiac CT scan. CT allows very detailed anatomical imaging and now physiological and plaque information that can be useful in pre-planning interventional procedures. Imaging from the GE Revolution Apex system at SCCT 2022.

VIDEO: CT imaging to plan coronary interventions — Interview with Jonathon Leipsic, MD

Jonathon Leipsic, MD, chairman of the Department of Radiology, University of British Columbia, explains how noninvasive computed tomography angiography (CTA) can be used to aid in planning interventional cardiology procedures for percutaneous coronary intervention (PCI) and chronic total occlusions (CTO).

Left, coronary CT angiography of a vessel showing plaque heavy calcium burden. Right, image showing color code of various types of plaque morphology showing the complexity of these lesions. The right image was processed using the FDA cleared, AI-enabled plaque assessment from Elucid.

Cardiac CT soft plaque assessment may offer paradigm shift for coronary disease screening

New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting.

VIDEO: Top 6 takeaways from the Society of Cardiovascular CT 2022 meeting

Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shared his key takeaways from the SCCT 2022 conference.

Cardiologists applaud new research on social/structural determinants of health among heart patients

The American Heart Association and Association of Black Cardiologists announced the winners of a six-month data challenge, describing health equity as "one of the most pressing areas in healthcare.”

Brijeshwar Maini, MD, FACC, structural heart cardiologist, national and Florida medical director of cardiology, explains his decision to leave clinical practice in the near future to become a full-time cardiac device manufacture business owner. It is a path several prominent cardiologists have made.

VIDEO: How this cardiologist became a full-time inventor and entrepreneur

Brijeshwar Maini, MD, explains his decision to leave clinical practice to become a full-time cardiac device business owner. It is a path several prominent cardiologists have made.

Adam Greenbaum, MD, transcatheter electrosurgery to prevent left ventricular outflow tract (LVOT) obstruction using a new procedure called Septal Scoring Along the Midline Endocardium (SESAME). The transcatheter procedure mimicking surgical myotomy.

VIDEO: Transcatheter myectomy to prevent LVOT obstruction in mitral valve replacement

Adam Greenbaum, MD, explains how transcatheter electrosurgery can be used to prevent left ventricular outflow tract (LVOT) obstruction using a new procedure called Septal Scoring Along the Midline Endocardium (SESAME).

Cardiology Associations

Advances in electrosurgical techniques have helped thousands of transcatheter valve patients

3D echo guidance seeing increasing use in congenital heart surgery

ESC Congress broke new record with over 33,000 attendees

Johnson & Johnson’s PFA platform is both safe and effective, real-world data confirm

Real-world data link semaglutide, tirzepatide to improved heart failure outcomes